conversion chart from semaglutide to tirzepatide Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are What is the dosage conversation

A gynecologist or an endocrinologist can provide guidance on managing the hormonal shifts that occur during this phase of life

Food and Drug Administration (FDA) has asked manufacturers to remove suicide risk warnings from several widely used weight loss medications after a comprehensive safety review found no evidence linking these drugs to increased suicidal thoughts or behaviors

Available from: Wilding JPH, Batterham RL, Calanna S, et al

When used for type 2 diabetes, the dosing recommendations are: Immediate-release tablet: 500 mg once or twice daily, or 850 mg once daily Extended-release tablet: 500 mg1,000 mg once daily For weight loss, PCOS, gestational diabetes, or other off-label uses of metformin, the dosage varies but most people start at 500 mg

Contribution of glycation and oxidative stress to thyroid gland pathology-a pilot study